We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+20.65%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$24.3M
(+32%)
Cap. Flow
+$6.54M
Cap. Flow
% of AUM
6.51%
Top 10 Holdings %
Top 10 Hldgs %
56.12%
Holding
218
New
50
Increased
37
Reduced
21
Closed
27
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
1.9
quarters
Top 20 Avg Time Held Equity + Options
2.2
quarters
Avg Time Held Equity only
4.7
quarters
Top 10 Avg Time Held Equity only
2.6
quarters
Top 20 Avg Time Held Equity only
2.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.77M |
| 2 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$661K |
| 3 |
Agios Pharmaceuticals
AGIO
|
+$653K |
| 4 |
Micron Technology
MU
|
+$610K |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$487K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.06M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$823K |
| 3 |
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
|
+$578K |
| 4 |
BVA
CORDIA BANCORP INC COM
BVA
|
+$499K |
| 5 |
Opko Health
OPK
|
+$349K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.64% |
| 2 | Miscellaneous | 21.13% |
| 3 | Healthcare | 14.92% |
| 4 | Technology | 7.13% |
| 5 | Consumer Discretionary | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IPHI
26
DELISTED
INPHI CORPORATION
IPHI
| $653K | 0.65% |
15,000
-3,000
| -17% | -$116K |
2015 Q1
6 quarters
|
|
|
COWN
27
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $653K | 0.65% |
45,000
| – | – |
2013 Q2
13 quarters
|
|
|
28
Opko Health
OPK
$1.03B
| $635K | 0.63% |
60,000
-35,000
| -37% | -$349K |
2013 Q2
13 quarters
|
|
29
ON Semiconductor
ON
$29.6B
| $616K | 0.61% |
50,000
+17,000
| +52% | +$176K |
2016 Q1
2 quarters
|
|
|
TOO
30
DELISTED
Teekay Offshore Partners L.P.
TOO
| $594K | 0.59% |
94,000
-5,000
| -5% | -$27.8K |
2015 Q4
3 quarters
|
|
31
Aclaris Therapeutics
ACRS
$530M
| $576K | 0.57% |
22,500
+5,000
| +29% | +$106K |
2015 Q4
3 quarters
|
|
|
CPE
32
DELISTED
Callon Petroleum Company
CPE
| $548K | 0.55% |
3,490
+1,990
| +133% | +$263K |
2016 Q2
1 quarter
|
|
33
Blackstone Mortgage Trust
BXMT
$1.83B
| $507K | 0.51% |
17,200
| – | – |
2013 Q2
13 quarters
|
|
34
DELISTED
Calavo Growers
CVGW
| $491K | 0.49% |
7,500
+3,500
| +88% | +$227K |
2016 Q1
2 quarters
|
|
35
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $462K | 0.46% |
100,000
| – | – |
2013 Q2
13 quarters
|
|
36
DELISTED
Farmer Brothers
FARM
| $444K | 0.44% |
12,500
+2,500
| +25% | +$80.7K |
2013 Q2
13 quarters
|
|
37
Nutanix
NTNX
$20.1B
| $422K | 0.42% |
+11,400
| New | +$422K |
2016 Q3
0 quarters
|
|
38
Magnachip Semiconductor
MX
$213M
| $417K | 0.42% |
50,000
+40,000
| +400% | +$291K |
2016 Q2
1 quarter
|
|
39
Par Pacific Holdings
PARR
$4.16B
| $412K | 0.41% |
31,500
+6,500
| +26% | +$90.7K |
2014 Q3
8 quarters
|
|
|
HEOP
40
DELISTED
Heritage Oaks Bancorp
HEOP
| $405K | 0.4% |
49,425
-40,975
| -45% | -$335K |
2013 Q2
13 quarters
|
|
41
DELISTED
HarborOne Bancorp
HONE
| $394K | 0.39% |
44,875
| – | – |
2016 Q2
1 quarter
|
|
42
ICICI Bank
IBN
$101B
| $374K | 0.37% |
55,000
+33,000
| +150% | +$230K |
2014 Q2
9 quarters
|
|
|
AVHI
43
DELISTED
A V Homes, Inc.
AVHI
| $374K | 0.37% |
22,500
-7,500
| -25% | -$108K |
2013 Q2
13 quarters
|
|
44
CALL
DELISTED
Exact Sciences
EXAS
| $371K | 0.37% |
20,000
| – | – |
2016 Q2
1 quarter
|
|
|
FNM.PRS
45
DELISTED
FEDERAL NATIONAL MORTGAGE ASSOCIATION PFD SER S (USA)
FNM.PRS
| $369K | 0.37% |
105,000
| – | – |
2013 Q3
12 quarters
|
|
|
VIVE
46
DELISTED
VIVEVE MED INC
VIVE
| $361K | 0.36% |
50
+26
| +108% | +$173K |
2016 Q2
1 quarter
|
|
47
McCormick & Company Non-Voting
MKC
$12.3B
| $350K | 0.35% |
+7,000
| New | +$355K |
2016 Q3
0 quarters
|
|
48
Block Inc
XYZ
$46.2B
| $350K | 0.35% |
+30,000
| New | +$328K |
2016 Q3
0 quarters
|
|
49
Acadia Pharmaceuticals
ACAD
$3.34B
| $343K | 0.34% |
10,785
-4,215
| -28% | -$143K |
2016 Q2
1 quarter
|
|
|
RNDB
50
DELISTED
Randolph Bancorp, Inc. Common Stock
RNDB
| $341K | 0.34% |
+25,000
| New | +$320K |
2016 Q3
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2016 Portfolio in Review
As of Q3 2016, E.E. Geduld held 218 positions worth $100M, up 32% from $76M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
E.E. Geduld deployed $6.54M of net new capital in Q3 2016, opening 50 new positions and adding to 37 existing holdings. Its largest new stake was Agios Pharmaceuticals: 15,000 shares worth $792K.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Opko Health, an estimated $349K trimmed.
- E.E. Geduld's largest Q3 2016 buy was Agios Pharmaceuticals: 15,000 shares worth $792K.
- E.E. Geduld added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.77M increase.
- E.E. Geduld's biggest Q3 2016 reduction was Opko Health, cutting an estimated $349K.
- E.E. Geduld fully exited Tesla in Q3 2016, selling an estimated $1.06M.
- E.E. Geduld's ten largest holdings make up 56% of its $100M portfolio in Q3 2016.
- E.E. Geduld opened 50 new positions and closed 27 in Q3 2016.
- E.E. Geduld's portfolio value rose 32% quarter-over-quarter to $100M.
Based on E.E. Geduld's 13F filing for Q3 2016, filed 2 Nov 2016.